Effect of erythromycin and rifampicin on monoethylglycinexylidide test
2008

Impact of Erythromycin and Rifampicin on Liver Function Test

Sample size: 20 publication Evidence: low

Author Information

Author(s): Bhise Satish Balkrishna, Dias Remeth Jacky

Primary Institution: Govt. College of Pharmacy, Vidyanagar, Karad, India

Hypothesis

The study aims to evaluate the effect of CYP3A4 modifiers erythromycin and rifampicin on the MEGX test.

Conclusion

The MEGX test is not affected by the concomitant administration of rifampicin and erythromycin.

Supporting Evidence

  • Rifampicin increased MEGX concentrations, but the change was not statistically significant.
  • Erythromycin decreased MEGX concentrations, but this effect was also not statistically significant.
  • The study included only healthy male volunteers, which may not represent the general population.

Takeaway

This study looked at how two medications affect a liver test, and it found that they don't change the test results.

Methodology

Twenty healthy male volunteers were given lidocaine, followed by either erythromycin or rifampicin for six days, and MEGX concentrations were measured.

Limitations

The study only included healthy male volunteers, which may limit the generalizability of the results.

Participant Demographics

Twenty healthy male volunteers with normal laboratory tests.

Statistical Information

P-Value

P = 0.085 for MEGX30 and P = 0.051 for MEGX60 with rifampicin; P = 0.128 for MEGX30 and P = 0.159 for MEGX60 with erythromycin.

Digital Object Identifier (DOI)

10.4103/0253-7613.41044

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication